Arno Siever

Statistics

Publications

Citations

1.2K

H-Index

Active since

2009

Affiliations

University Hospital of Basel(Current)

University of Basel

St. Josef-Hospital

Novartis (Switzerland)

Arno Siever is an author at University Hospital of Basel specializing in relapsing-remitting multiple sclerosis treatment, multiple sclerosis pharmacotherapy, and multiple sclerosis therapy.

Publications per year

2009–2018

Publications

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

Ralf Gold, Jacqueline Palace, Arno Siever et al. · Journal of Neurology · 2013 · 126 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Quality of life in 1000 patients with early relapsing–remitting multiple sclerosis

Norman Putzki, Jill S. Fischer, K.R.K. Gottwald et al. · European Journal of Neurology · 2009 · 77 citations

Life Sciences, Internal Medicine, Neurology +17

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

Wolfgang H. Oertel, Yngve Hallström, G. Saletu‐Zyhlarz et al. · CNS Drugs · 2016 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN

Antonios Bayas, Katrin Schuh, Monika Baier et al. · Therapeutic Advances in Neurological Disorders · 2016 · 19 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

1–5 of 6